Our Group was launched in May 2006. Since then more than 65 study sites are participating in this Group. The participating study sites are Intensive Care Units, Departments of Internal Medicine and Departments of Surgery from Greece and Cyprus. Our common goals are fostering education and research in sepsis and collaborating with groups with the same goals in Europe and further abroad. The main activities and skills developed by the Hellenic Sepsis Study Group over the years constitute a dynamic interplay between management, education and research
The Hellenic Sepsis Study Group has strong management allowing the daily contact with the administration of the hospitals of the participating study sites. Management comprises organization of conferences and workshops, drafting of protocols, submissions for Institutional and Regulatory approval, monitoring services, central lab facility, secretarial facilities and electronic portal facilities.
The educational activities of the Hellenic Sepsis Study Group comprise the organization of: a) 10 conferences/workshops in Greece, b) the international conferences on Bloodstream Infections in Athens in May 2010, in Limassol in November 2012 and in Vravrona in June 2015, c) the publication of four bulletins for the management of sepsis in November 2008, April 2011, March 2014 and June 2017, d) the publication into supplementary volumes of the International Journal of Antimicrobial Agents of the papers presented during the international conferences on bloodstream infections and e) the completion of 16 PhDs.
The research activities of the Hellenic Sepsis Study Group were initially focused on a common research protocol that focused on the individualized traits of pathophysiology of the host. This on-going protocol has enrolled so far more than 7,000 patients. Since 2014, the research activities expanded to the conduct of randomized clinical trials on the use of biomarkers (studies INTELLIGENCE, PROMPT, PROGRESS, and SPECIFY), newer antimicrobials (studies AIDA and SUPERIOR) and strategies of immunotherapy (studies INCLASS, PROVIDE).
Our website is providing full details for all these activities. We do hope that surfing our website will fascinate young researchers to embrace these activities and will strengthen older collaborators on the merit of this long-standing collaboration.
Professor Charalambos Gogos
Professor Evangelos J. Giamarellos-Bourboulis